Skip header and navigation

9 records – page 1 of 1.

Adverse reactions between alcohol and drug products

https://policybase.cma.ca/en/permalink/policy805
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Less detail

Antibiotics used in the raising of farm animals

https://policybase.cma.ca/en/permalink/policy10211
Date
2011-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC11-88
The Canadian Medical Association recommends that a prescription from a veterinarian be required for all antibiotics used in the raising of farm animals or for any other agricultural purpose.
Policy Type
Policy resolution
Last Reviewed
2018-Mar-03
Date
2011-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC11-88
The Canadian Medical Association recommends that a prescription from a veterinarian be required for all antibiotics used in the raising of farm animals or for any other agricultural purpose.
Less detail

Canadian Disclosure Guidelines: Being Open with Patients and Families

https://policybase.cma.ca/en/permalink/policy10367
Date
2011-Dec-03
Topics
Health care and patient safety
Health information and e-health
Resolution
BD12-03-66
The Canadian Medical Association endorses the Canadian Patient Safety Institute’s document Canadian Disclosure Guidelines: Being Open with Patients and Families as outlined in Appendix A to BD 12-61.
Policy Type
Policy resolution
Last Reviewed
2018-Mar-03
Date
2011-Dec-03
Topics
Health care and patient safety
Health information and e-health
Resolution
BD12-03-66
The Canadian Medical Association endorses the Canadian Patient Safety Institute’s document Canadian Disclosure Guidelines: Being Open with Patients and Families as outlined in Appendix A to BD 12-61.
Less detail

Drug product substitution

https://policybase.cma.ca/en/permalink/policy806
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Less detail

Insite: CMA submission regarding Insite supervised injection site and program.

https://policybase.cma.ca/en/permalink/policy14129
Date
2011-Feb-17
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  

Medication use and seniors (Update 2017)

https://policybase.cma.ca/en/permalink/policy10151
Date
2011-May-28
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
  1 document  
Policy Type
Policy document
Last Reviewed
2019-Mar-03
Date
2011-May-28
Replaces
Medication use and seniors
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Documents
Less detail

Principles for the development, use and evaluation of health care databases

https://policybase.cma.ca/en/permalink/policy579
Date
1997-Aug-20
Topics
Health information and e-health
Ethics and medical professionalism
Resolution
GC97-26
That physicians, through the Canadian Medical Association, its Divisions and affiliates, should be involved in delineating principles to guide the development, use and evaluation of databases that provide linkages between health care utilization, socioeconomic status and other determinants of health and health status.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1997-Aug-20
Topics
Health information and e-health
Ethics and medical professionalism
Resolution
GC97-26
That physicians, through the Canadian Medical Association, its Divisions and affiliates, should be involved in delineating principles to guide the development, use and evaluation of databases that provide linkages between health care utilization, socioeconomic status and other determinants of health and health status.
Less detail

Risk of acetaminophen overdose

https://policybase.cma.ca/en/permalink/policy10209
Date
2011-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC11-79
The Canadian Medical Association recommends that all over-the-counter preparations containing acetaminophen have a prominent warning on the front of the packaging that informs consumers about the risk of acetaminophen overdose.
Policy Type
Policy resolution
Last Reviewed
2018-Mar-03
Date
2011-Aug-24
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC11-79
The Canadian Medical Association recommends that all over-the-counter preparations containing acetaminophen have a prominent warning on the front of the packaging that informs consumers about the risk of acetaminophen overdose.
Less detail

Testing of antibiotics

https://policybase.cma.ca/en/permalink/policy10157
Date
2011-Aug-24
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
Resolution
GC11-69
The Canadian Medical Association supports the routine testing of antibiotics manufactured in or imported into Canada to ensure that they all comply with the labelling on the containers.
Policy Type
Policy resolution
Last Reviewed
2018-Mar-03
Date
2011-Aug-24
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
Resolution
GC11-69
The Canadian Medical Association supports the routine testing of antibiotics manufactured in or imported into Canada to ensure that they all comply with the labelling on the containers.
Less detail

9 records – page 1 of 1.